nuvox_logo 1000 - svg.jpg

  • Pipeline

  • Leadership

  • News

    • Events

  • Publications

    • Acute Hypoxemic Respiratory Failure
    • Hemorrhagic Shock
    • Mechanism Of Action
    • Myocardial Infarction
    • Oncology
    • Pharmacokinetics
    • Stroke
    • Traumatic Brain Injury

  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    The latest from NuvOx

    • All Posts
    • News
    • Events
    • Publications
    • Hemorrhagic Shock
    • Mechanism Of Action
    • Myocardial Infarction
    • Oncology
    • Pharmacokinetics
    • Stroke
    • Traumatic Brain Injury
    • Other
    Search
    Imaging assessment of cardioprotection mediated by DDFPe administered during myocardial infarction
    • Mar 1, 2019

    Imaging assessment of cardioprotection mediated by DDFPe administered during myocardial infarction

    DDFPe treatment in rats with myocardial infarction was associated by significantly reduced ischemia-reperfusion injury.
    DDFPe Elicits Cardiac Protection Against Myocardial Infarction
    • Oct 16, 2014

    DDFPe Elicits Cardiac Protection Against Myocardial Infarction

    Rats given DDFPe see a 72% reduction in myocardial infarct volume at 24 hours.
    • Pipeline
    • Leadership
    • News
      • Events
    • Publications
      • Acute Hypoxemic Respiratory Failure
      • Hemorrhagic Shock
      • Mechanism Of Action
      • Myocardial Infarction
      • Oncology
      • Pharmacokinetics
      • Stroke
      • Traumatic Brain Injury
    • Careers
    • Contact

    NuvOx Pharma

    1635 E 18th Street

    Tucson, Arizona 85719

    ​

    Privacy Policy

    Terms & Conditions

    Company FCOI

    ​

    © 2020 NuvOx Pharma